Despite the fact that rhGH is available since 1985 there are several questions related to its use that remain unanswered.
Ernest L. Mazzaferri
Thyroid cancer, which is the most common endocrine malignancy, has been progressively increasing from 1972 through 2002, largely as the result of an increasing incidence of small papillary thyroid cancers, the majority of which are Ͻ2 cm that have increased almost 3-fold during the 30-year study. During this time, thyroid cancer was found to affect women more often than men by a ratio of almost 3 to 1. Moreover, papillary thyroid cancer was found to be the most common form of differentiated thyroid cancer among women of childbearing age, 10% of whom were either pregnant or in the early postpartum period when thyroid cancer was diagnosed. Although the prevalence of thyroid cancer in pregnant women remains high, most are first identified after delivery. Nonetheless, the management of thyroid cancer during pregnancy poses serious diagnostic and therapeutic challenges to both the patient and fetus. Thyroid gland may secrete more thyroid hormone than usual during early pregnancy, which may not only be the cause of this problem, but may be responsible for the higher rate of differentiated thyroid cancer during pregnancy. There is concern about therapy for thyroid cancer during this period, including the timing of surgery, the use of levothyroxine and the assessment of follow-up during gestation.
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The Prevalence of Occult Medullary Thyroid Carcinoma at Autopsy Laticia A. Valle and Richard T. Kloos
Context: The prevalence of occult medullary thyroid carcinoma (MTC) in the general population is unknown but may be important when considering strategies to diagnose clinically relevant MTC in nodular goiter or other populations.
Objective: Our objective was to determine the prevalence of occult MTC in an autopsy series.
Design: We conducted systematic review of autopsy series from 1970 to present using a PubMed search.
Patients: The patients came from 21 countries, ages ranged from 6 -95 yr, both genders were represented, and none had clinical evidence of thyroid disease before autopsy.
Intervention: Three series were excluded based on tumor size less than 500 m, non-English language, or insufficient information.
Main Outcome Measure: Prevalence of occult MTC was calculated.
Results: An average prevalence of 0.14 and 7.6% for occult MTC and papillary thyroid carcinoma, respectively, was found among 7897 autopsies from 24 published series. Greater than 75% of patients with MTC were more than 60 yr old, and male to female ratio was comparable. Tumor size was virtually all subcentimeter, and there was no lymph node spread, extrathyroidal extension, or distant metastases reported.
Conclusions: A small number of people in the general population, who do not have known thyroid disease, have occult MTC and die of other causes. This finding of untreated occult MTC without morbidity or mortality should be considered in population prevalence studies, when strategies to detect thyroid neoplasia are considered (e.g. serum calcitonin or ultrasound), and included in cost-effectiveness models of routine serum calcitonin screening for nodular thyroid disease. Metab, 10.1210 Metab, 10. /jc.2010 
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Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity
Munro Peacock, J. P. Bilezikian, M. A. Bolognese, Michael Borofsky, Simona Scumpia, Lulu Ren Sterling, Sunfa Cheng, and Dolores Shoback Context: Primary hyperparathyroidism (PHPT) is characterized by elevated serum calcium (Ca) and increased PTH concentrations.
Objective: The objective of the investigation was to establish the efficacy of cinacalcet in reducing serum Ca in patients with PHPT across a wide spectrum of disease severity.
Design and Setting: The study was a pooled analysis of data from three multicenter clinical trials of cinacalcet in PHPT.
Patients : Patients were grouped into three disease categories for analysis based on the following: 1) history of failed parathyroidectomy (n ϭ 29); 2) meeting one or more criteria for parathyroidectomy but without prior surgery (n ϭ 37); and 3) mild asymptomatic PHPT without meeting criteria for either above category (n ϭ 15). 
